A detailed history of Fora Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Fora Capital, LLC holds 69,487 shares of INSM stock, worth $5.06 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
69,487
Holding current value
$5.06 Million
% of portfolio
0.59%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $1.53 Million - $4.84 Million
69,487 New
69,487 $4.66 Million
Q4 2020

Feb 12, 2021

SELL
$31.45 - $40.54 $42,017 - $54,161
-1,336 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$26.0 - $34.5 $77,792 - $103,224
-2,992 Reduced 69.13%
1,336 $43 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $8,212 - $17,122
582 Added 15.54%
4,328 $119 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $7,401 - $18,451
543 Added 16.95%
3,746 $60,000
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $51,632 - $80,010
3,203 New
3,203 $76,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.87B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.